E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Recruiting

Phase 2

E7 TCR-T Cell ImmunotherapyE7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Sponsor:

Christian Hinrichs

Code:

NCT05686226

Conditions

Cervical Cancer

Throat Cancer

Oropharynx Cancer

Anal Cancer

Vulva Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

E7 TCR-T cells

Aldesleukin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Christian Hinrichs on 2025-03-30.